Paraplegia following intrathecal methotrexate.
D002556:Cerebrospinal Fluid Proteins / Q000032:analysis; D002648:Child; D004906:Erythrocyte Count; D005260:Female; D005947:Glucose / Q000134:cerebrospinal fluid; D006801:Humans; D007278:Injections, Spinal / Q000009:adverse effects*; D007938:Leukemia / Q000188:drug therapy; D007958:Leukocyte Count; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects* / Q000134:cerebrospinal fluid; D010264:Paraplegia / Q000139:chemically induced*; D012075:Remission, Spontaneous
D002556:Cerebrospinal Fluid Proteins; D005947:Glucose; D008727:Methotrexate